secwatch.observer — SEC 8-K summary
======================================

Issuer:     IGC Pharma, Inc. (IGC)
CIK:        0001326205
Form:       8-K
Filed at:   2024-08-27T23:59:59+00:00
Accession:  0001185185-24-000851
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.07, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

IGC Pharma stockholders re-elect two directors, ratify auditor, approve 5M share grant
--------------------------------------------------------------------------------

- Richard Prins (26,116,740 for) and Terry Lierman (27,800,503 for) re-elected as Class B directors until 2027.
- Ratified Manohar Chowdhry & Associates as independent registered public accounting firm for 2025 fiscal year (42,587,128 for).
- Approved grant of up to 5,000,000 common shares to employees, advisors, directors, and consultants.
- Non-binding advisory vote indicates executive compensation votes will be held every three years.
- Approximately 56.6% of outstanding shares (42,811,367) voted; 14,877,728 broker non-votes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1326205/000118518524000851/0001185185-24-000851-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1326205/000118518524000851/igc20240826_8k.htm
  HTML page:      https://secwatch.observer/filing/0001185185-24-000851

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer